ArticleJAAD case reports2021
Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab.
Article in JAAD case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.
- Pemphigoid diseases in patients with end-stage kidney diseases: pathogenesis and treatment.Frontiers in immunology · 2024Pooled it
- Updates in the Diagnosis and Management of Linear IgA Disease: A Systematic Review.Medicina (Kaunas, Lithuania) · 2021Pooled it
- Rituximab for linear immunoglobulin A bullous dermatosis.Dermatology reports · 2023Article
- Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin.American journal of clinical dermatology · 2023Review
- Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review.Cureus · 2023Review
- Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.Frontiers in immunology · 2023Review
- Annular bullous pemphigoid: A case report and review of literature.SAGE open medical case reports · 2022Article
- Uncommon and Unusual Variants of Autoimmune Bullous Diseases.Indian dermatology online journalReview
- Refractory linear IgA dermatosis in childhood: a successful response to rituximab.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.